Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2018Journal of the National Comprehensive Cancer NetworkOpen Access

NCCN Guidelines Insights: Bladder Cancer, Version 5.2018

View Full Paper
Ask AI
Bookmark
Share

Authors

TFThomas W. FlaigUniversity of Colorado Cancer CenterPSPhilippe E. SpiessMoffitt Cancer CenterNANeeraj AgarwalHuntsman (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Flaig et al. (2018) studied this question.

synapsesocial.com/papers/6aa56869bc2c7db7488e3d44https://doi.org/10.6004/jnccn.2018.0072
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy1999 · 732 citations
  2. 2Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.1993 · 318 citations
  3. 3Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.1996 · 472 citations